Biologic Drug Product CM Quality Benchmarking Report 2020: A Look at Small & Emerging Biopharma - ResearchAndMarkets.com

DUBLIN--()--The "Biologic Drug Product Contract Manufacturer Quality Benchmarking: A Look at Small & Emerging Biopharma" report has been added to ResearchAndMarkets.com's offering.

This report is an-depth look at a subset of respondents from small and emerging biopharma companies. The findings in this report will help small and emerging biopharmaceutical companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies to better accommodate this segment.

The report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing philosophies and practices, CMO selection drivers, and CMO perceptions and interactions. Findings are based on 25 respondents.

What You Will Learn

Small & Emerging Drug Developers

  • Make a more educated purchase of CMO services by understanding which manufacturers best fit your company's needs
  • Uncover which CMO attributes drive outsourcing partner selection for outsourced biologic drug product manufacturing as well as which CMO attributes have gained importance over the past 12 months among industry peers
  • Understand overall CMO customer loyalty via ratings of customer satisfaction, willingness to recommend, and likelihood to use again

Contract Manufacturers

  • Understand your company's market awareness and positioning, and use this information to develop targeted messaging to small and emerging biopharma companies
  • Gain insight into small and emerging drug developers' preferences and practices with respect to CMO selection and CMO preference for outsourced biologic drug product manufacturing

Key Topics Covered

1. Outsourcing Philosophies and Practices

  • Primary Section Takeaways
  • Outsourced Manufacturing Activities
  • Outsourcing Drivers
  • Outsourcing Models
  • Large Molecule Product Offering
  • Large vs. Small Molecule Outsourcing
  • Preferred Providers
  • Number of Preferred Providers

2. CMO Selection Drivers

  • Primary Section Takeaways
  • Most Important CMO Attributes
  • CMO Attributes Gaining Importance

3. CMO Perceptions and Interactions

  • Primary Section Takeaways
  • CMO Familiarity
  • CMO Leaders - Unprompted
  • CMO Leaders - Prompted
  • Received Proposals
  • CMO Use
  • CMO Preference
  • CMO Preference Among Users
  • CMO Cost Perceptions
  • Summary Table
  • CMO Loyalty

4. Study Data

  • Outsourced Manufacturing Activities
  • Outsourcing Drivers
  • Outsourcing Models
  • Use of Preferred Providers
  • Number of Preferred Providers
  • Large Molecule Product Offering
  • Large vs. Small Molecule Outsourcing
  • CMO Selection Attributes
  • CMO Selection Attributes Gaining
  • Importance
  • CMO Leaders - Unprompted
  • CMO Familiarity
  • CMO Leaders - Prompted
  • Received Proposals
  • CMO Use
  • CMO Preference
  • CMO Cost Perceptions

5. Demographics

  • Company Type
  • Headquarters Location
  • Office Location
  • Job Title
  • Decision-making Responsibility
  • Biologic Drug Product Outsourcing
  • Contract Manufacturing Responsibilities
  • Involvement in Outsourced Manufacturing
  • Contract Manufacturing Involvement
  • Years of Industry Experience

For more information about this report visit https://www.researchandmarkets.com/r/1cxduv

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900